| Model Number |
SIGSDS30CTV |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); Tissue Breakdown (2681)
|
| Date of Event |
04/22/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during a video-assisted thoracic lobectomy, when the device was used on one of the pulmonary vessels, the staple line was oozier than the surgeon normally expected.The surgeon used a metal clip under the staple line to resolve the bleeding.
|
| |
|
Additional Manufacturer Narrative
|
|
Evaluation summary: medtronic conducted an investigation based upon all information received.The device and a photo were available for evaluation.A video was also provided.Visual inspection noted that the tissue cavity could be seen from one monitor.There were loose staples and blood pooling in the cavity, but the reload was not visible on the images and video.Functional testing found that the reload was loaded into a representative instrument.The interlock was overridden, and the reload was cycled without hesitation or binding.Test media was cleanly transected, and the reload interlock was tested and found to function properly.It was reported that the staple line was bleeding.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|